MORGAN STANLEY - CYCLO THERAPEUTICS INC ownership

CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 14 filers reported holding CYCLO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CYCLO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$586
-10.8%
4130.0%0.00%
Q2 2023$657
+76.6%
413
-6.8%
0.00%
Q1 2023$372
-40.9%
4430.0%0.00%
Q4 2022$629
-37.1%
4430.0%0.00%
Q3 2022$1,0000.0%4430.0%0.00%
Q2 2022$1,000
-50.0%
443
-11.9%
0.00%
Q1 2022$2,000
-33.3%
503
-37.4%
0.00%
Q4 2021$3,0000.0%803
+59.6%
0.00%
Q3 2021$3,000
-78.6%
503
-64.1%
0.00%
Q2 2021$14,000
+250.0%
1,403
+178.9%
0.00%
Q1 2021$4,000503
+458.9%
0.00%
Q4 2020$0900.00%
Other shareholders
CYCLO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
XTX Topco Ltd 12,900$18,3180.00%
Virtu Financial LLC 10,732$150.00%
Tower Research Capital LLC (TRC) 6,767$9,6090.00%
JPMORGAN CHASE & CO 240$3410.00%
ROYAL BANK OF CANADA 746$1,0000.00%
VANGUARD GROUP INC 282,027$400,4780.00%
UBS Group AG 88$1250.00%
IFP Advisors, Inc 13$180.00%
OSAIC HOLDINGS, INC. 600$8520.00%
WELLS FARGO & COMPANY/MN 2,352$3,3400.00%
View complete list of CYCLO THERAPEUTICS INC shareholders